PTC Therapeutics, Inc. (PTCT) Financials

PTCT Assets vs Liabilities
DateAssetsLiabilities
March 31, 2026 2.9 billion 3.0 billion
Dec. 31, 2025 2.9 billion 3.1 billion
Sept. 30, 2025 2.6 billion 2.8 billion
June 30, 2025 2.6 billion 2.8 billion

PTCT Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
March 31, 2026 -60.2 million ?
Dec. 31, 2025 -36.6 million 18.5 million
Sept. 30, 2025 -69.7 million 19.4 million
June 30, 2025 -62.3 million 18.5 million

PTCT Net Income

No data available :(

PTCT Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
March 31, 2026 1.9 billion - 90.1 million
Dec. 31, 2025 1.9 billion 93.6 million 96.6 million
Sept. 30, 2025 1.7 billion 95.5 million 109.3 million
June 30, 2025 2.0 billion 286.0 million 102.2 million

PTCT Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
March 31, 2026 82.5 million
Dec. 31, 2025 80.7 million
Sept. 30, 2025 87.1 million
June 30, 2025 78.2 million

PTCT Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
March 31, 2026 1.2 million 100.9 million 86.2 million -
Dec. 31, 2025 2.4 million 133.1 million 100.5 million -
Sept. 30, 2025 3.4 million 100.2 million 84.0 million -
June 30, 2025 4.0 million 113.0 million 85.3 million -

PTCT Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
March 31, 2026 272.6 million 39.6 million
Dec. 31, 2025 164.7 million 16.3 million
Sept. 30, 2025 211.0 million 115.9 million
June 30, 2025 178.9 million 11.4 million

PTCT Revenue by Segment
Graph available only for paid members. Upgrade to see it.

PTCT

Price: $73.88

52 week price:
43.18
87.50

Earnings Per Share: -2.54 USD

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Country: United States

Volume: 588300

Ebitda: -20.6 million

Market Capitalization: 5.7 billion

Links: